Narrow search
Showing 1 - 10 of 7,466
Cover Image
Market response to FDA announcements
Sarkar, Salil K.; Jong, Pieter J. de - In: The quarterly review of economics and finance : journal … 46 (2006) 4, pp. 586-597
Persistent link: https://www.econbiz.de/10003416646
Cover Image
FDA decisions on new drug applications and the market value of pharmaceutical firms
Torabzadeh, Khalil M. - In: American business review 16 (1998) 2, pp. 42-50
Persistent link: https://www.econbiz.de/10001245772
Cover Image
Wealth effects of the Drug Price Competition and Patent Term Restoration Act of 1984
Brastow, Raymond T. - In: The American economist : journal of Omnicron Delta … 32 (1988) 2, pp. 59-65
Persistent link: https://www.econbiz.de/10001087746
Cover Image
The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies
Chen, Yong-Jie; Feng, Zhi-Yuan; Li, Yueh-Ping; Huang, … - In: Innovation: organization & management : IOM 23 (2021) 3, pp. 354-374
Persistent link: https://www.econbiz.de/10012649635
Cover Image
The signaling effects of incremental information : evidence from stacked US Food and Drug Administration designations
Miller, Kathleen L.; Nardinelli, Clark; Pink, George H.; … - In: The quarterly review of economics and finance : journal … 67 (2018), pp. 219-226
Persistent link: https://www.econbiz.de/10012034461
Cover Image
Do "reverse payment" settlements of brand-generic patent disputes in the pharmaceutical industry constitute an anticompetitive pay for delay?
Drake, Keith M.; Starr-McCluer, Martha; McGuire, Thomas G. - 2014
Persistent link: https://www.econbiz.de/10010391799
Cover Image
Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?
Drake, Keith - 2014
Brand and generic drug manufacturers frequently settle patent litigation on terms that include a payment to the generic … generic, and conduct an event study of the announcement of the patent settlements on the stock price of the brand. For …
Persistent link: https://www.econbiz.de/10013050310
Cover Image
Stock price evidence for anticompetitive effects in the nexium "reverse-payment" settlement
Drake, Keith M.; McGuire, Thomas G. - In: Journal of competition law & economics 12 (2016) 4, pp. 735-747
Persistent link: https://www.econbiz.de/10011660496
Cover Image
Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?
Drake, Keith M. - 2014
Brand and generic drug manufacturers frequently settle patent litigation on terms that include a payment to the generic … generic, and conduct an event study of the announcement of the patent settlements on the stock price of the brand. For …
Persistent link: https://www.econbiz.de/10012458375
Cover Image
An event study of patent verdicts and judicial leakage
Engelhardt, Bryan; Fernandes, Zachary - 2016
Persistent link: https://www.econbiz.de/10011575596